Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-22-012325

Director bought 175,132 shares at an average $1.47 ($256,970)

From the SEC's structured data for this filing

Trades in this filing

HILZINGER KURT J · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-02-22 Purchase : show line 1 in the form +95,597 $1.49 $142,440 118,714 D
2022-02-23 Purchase : show line 2 in the form +79,535 $1.44 $114,530 198,249 D
Open-market purchases · 175,132 sh · avg $1.47 · $256,970
Loading xslF345X03/doc4.xml…